Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies

Authors

William Tillett (ORCID: https://orcid.org/0000-0001-7531-4125)
Stefanie Hahne
Dafna D. Gladman (ORCID: https://orcid.org/0000-0002-9074-0592)
David Gruben (ORCID: https://orcid.org/0000-0003-3516-5289)
Laura C. Coates (ORCID: https://orcid.org/0000-0002-4756-663X)
Mikhail Volkov (ORCID: https://orcid.org/0000-0001-7577-2994)

Institutions

Royal National Hospital for Rheumatic Diseases (GB)
University Health Network (CA)
Pfizer (United States) (US)
Toronto Western Hospital (CA)
Nuffield Orthopaedic Centre (GB)
University of Oxford (GB)
Pfizer (Germany) (DE)
Pfizer (Netherlands) (NL)
Krembil Research Institute

Publication Details

Journal: RMD Open
Published: 2025-05-01
DOI: https://doi.org/10.1136/rmdopen-2024-005250
Primary Topic: Spondyloarthritis Studies and Treatments
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Pfizer

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies

William Tillett, Stefanie Hahne, Dafna D. Gladman, David Gruben et al.

May 1, 2025

1 links

RMD Open

Spondyloarthritis Studies and Treatments

article

Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies

William Tillett, Stefanie Hahne, Dafna D. Gladman, David Gruben, Laura C. Coates, Mikhail Volkov

May 1, 2025article en

Abstract

No abstract available for this paper.

RMD OpenVol. 11(2)

Royal National Hospital for Rheumatic Diseases (GB), University Health Network (CA), Pfizer (United States) (US), Toronto Western Hospital (CA), Nuffield Orthopaedic Centre (GB), University of Oxford (GB), Pfizer (Germany) (DE), Pfizer (Netherlands) (NL), Krembil Research Institute

Pfizer

Good health and well-being

Openalex Percentile: Top 80%

Spondyloarthritis Studies and Treatments

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies — William Tillett, Stefanie Hahne, et al. · RMD Open (2025) | TGRS Research Map | TGRS